Conference Proceedings

CME Credits

Continuing medical credits are no longer available for this course.

View Video of Conference

*These presentations were part of the CME/CNE-accredited live virtual conference held on February 11, 2022. Credits awarded only to those who viewed the presentations during the live conference. 

Agenda

Friday, February 11, 2022
7:30 am – 3:45 pm EST

*These presentations were part of the CME/CNE-accredited live virtual conference held on February 11, 2022. Credits awarded only to those who viewed the presentations during the live conference. 

7:30 am

Log-in to Virtual Conference - Visit Virtual Exhibit Hall

8:00 am

Welcome and Opening Remarks

Edward A Stadtmauer, MD, Activity Director
Robert H Vonderheide, MD, DPhil, Director, Abramson Cancer Center

Keynote Presentation

8:10 am

Equitable Access to Hematologic Malignancies Research for Everyone

Carmen E Guerra, MD, MSCE, FACP

8:40 am

Q & A Discussion

Moderator: Edward A Stadtmauer, MD

Panel: Carmen E Guerra, MD, MSCE, FACP
 

NEW THERAPIES AND CURRENT PATIENT MANAGEMENT OF LYMPHOMAS

Moderator: Stephen J Schuster, MD  |  Activity Co-Director

8:55 am

Advances in Indolent Lymphomas and CLL

Elise A Chong, MD

9:10 am

New Therapies for Mantle Cell Lymphoma

​​​James M Gerson, MD

9:25 am

Therapeutic Advances in Hodgkin Lymphoma

Jakub Svoboda, MD

9:40 am

Therapeutic Advances in T-Cell Lymphoma

Stefan K Barta MD, MS, MRCPCUK

9:55 am

Targeted Therapy of Aggressive B-Cell Lymphomas

Daniel J Landsburg, MD

10:10 am

DLCL: Immune Modulation Therapy including CART, Bispecific Ab, and New Antibodies

Sunita D Nasta, MD, FACP

10:25 am

Panel Discussion

Moderator: Stephen J Schuster, MD | Activity Co-Director

PANEL:
Stefan K Barta, MD, MS, MRCPCUK
Douglas F Beach, MD
Elise A Chong, MD
James M Gerson, MD
Gamil S Hanna, MD
Danielle Land, MSN, CRNP
Sunita D Nasta, MD, FACP
Jakub Svoboda, MD

10:45 am

Break and Visit Exhibits

UPDATE ON PATIENT CARE TREATMENT STRATEGIES IN LEUKEMIA

Moderator: Keith W Pratz, MD  |  Activity Co-Director 

10:55 am

Emerging Treatment Options for AML

Alexander E Perl, MD

11:10 am

Update in Treatment Strategies for MDS

Shannon R McCurdy, MD

11:25 am 

Update in CML and Myeloproliferative Disease

Elizabeth O Hexner, MD, MSTR

11:40 am  

The Direction of Leukemia Treatment Nationally and Around the World

Selina M Luger, MD

11:55 am

Panel Discussion

Moderator: Keith W Pratz, MD

PANEL:
Elizabeth O Hexner, MD, MSTR
Ximena Jordan Bruno, MD
Lindsay M Lee, CRNP
Selina M Luger, MD
Shannon R McCurdy, MD 
Sunil Saroha, MD

12:15 pm

Break and Visit Exhibits

UPDATE IN BLOOD AND MARROW TRANSPLANTATION AND CELLULAR THERAPY

Moderator: David L Porter, MD  |  Activity Co-Director

12:45 pm

Autologous SCT or CAR T Cells as Second Line for Relapsed/Refractory Lymphoma: Drivers, start your CARs early

David L Porter, MD

1:00 pm

CAR T-Cells and Immunotherapy for ALL

Noelle Frey, MD

1:15 pm

Increasing Access to Allogenic Transplant

Alison Wakoff Loren, MD, MSCE

1:30 pm

Panel Discussion

Panel Discussion 15 min

Moderator: David L Porter, MD

Panel:

Noelle Frey, MD
Stephen J Schuster, MD

CONTROVERSIES AND UPDATE FOR PATIENT CARE IN MULTIPLE MYELOMA

Moderator: Edward A Stadtmauer, MD  | Director

1:45 pm

Smoldering Myeloma and Myeloma Precursor States

Sandra P Susanibar-Adaniya, MD

2:05 pm

Initial Therapy for Multiple Myeloma Including Transplant

Alfred L Garfall, MD, MS

2:25 pm

Role of Immunotherapy for Myeloma

Adam D Cohen, MD 

2:45 pm

Experimental Therapies for Relapsed Myeloma

 Dan T Vogl, MD, MSCE

3:05 pm

Early Disease State – Amyloidosis

Adam Waxman, MD, MS

3:25 pm

Panel Discussion

Moderator:  Edward A Stadtmauer, MD
PANEL:
Adam D Cohen, MD 
Alfred L Garfall, MD, MTR
Patricia Mangan, MSN, CRNP
Sandra P Susanibar-Adaniya, MD
Dan T Vogl, MD, MSCE
Stephen G Wallace, MD
Adam Waxman, MD, MS

3:45 pm

Adjourn

View Video of Conference

Continuing medical credits are no longer available for this course.